Skip to Main Content

Paper Details

Identification of Novel Alectinib-Resistant <i>ALK</i> Mutation G1202K with Sensitization to Lorlatinib: A Case Report and in silico Structural Modelling.
Onco Targets Ther
2
2021
Author NameAffiliation
Xue WuNanjing Geneseeq Technology Inc.
Yang ShaoNanjing Geneseeq Technology Inc.
Yang ShaoSchool of Public Health, Nanjing Medical University
  • 1 - 3

Datasets

Release 1.2